Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

NCT06332092

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Highlands Oncology - North Hills Fayetteville, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Moffitt Cancer Center Magnolia Campus Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

NCT06727565

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Siteman Cancer Center St Louis, Missouri, United States
  • Tennessee Oncology, PLLC - Greco-Hainsworth Centers for Research Nashville, Tennessee, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Westmead Hospital Sydney, New South Wales, Australia
View all 23 locations
View Trial Details
Active, Not Recruiting

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

NCT01893307

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

NCT04868877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
Locations
  • University of California, Irvine Orange, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
  • Next Oncology Virginia Fairfax, Virginia, United States
View all 51 locations
View Trial Details

Related conditions